— Know what they know.
Not Investment Advice

GSAC OTC

GelStat Corporation
1W: -0.0% 1M: -0.0% 3M: +20.0% YTD: -14.3% 1Y: -14.3% 3Y: -25.0% 5Y: -96.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 50 · $185394 mcap · 530M float · 0.181% daily turnover · Short 22% of daily vol

Income Trends

Revenue
$350K +133.9% ▲
5Y CAGR: +11.7%
Gross Profit
$234K +79.1% ▲
5Y CAGR: +3.2%
Operating Income
-$281K -69.5% ▼
Net Income
-$373K -77.5% ▼
EPS (Diluted)
$-0.00 +50.0% ▲
EBITDA
-$251K -66.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$4K$7K$2K$150K$350K
YoY Growth-98.0%+77.8%-66.8%+6309.2%+133.9%
Cost of Revenue$135K$181K$410K$19K$116K
Gross Profit-$131K-$173K-$408K$131K$234K
Gross Margin-3307.0%-2463.7%-17488.2%87.3%66.9%
R&D Expenses$0$0$0$0$0
SG&A Expenses$47K$140K$529K$281K$484K
Operating Expenses$47K$140K$194K$296K$514K
Operating Income-$178K-$313K-$602K-$166K-$281K
Operating Margin-4494.9%-4457.4%-25803.7%-110.9%-80.3%
Interest Expense$2K$230K$17K$42K$94K
Income Before Tax-$178K-$475K-$761K-$207K-$373K
Tax Expense$0$0$0$0$0
Net Income-$178K-$475K-$761K-$210K-$373K
Net Margin-4502.2%-6764.5%-32618.9%-140.5%-106.7%
EPS (Diluted)$-0.00$-0.00$-0.00$-0.00$-0.00
EBITDA$2K$74K$8K-$150K-$251K
Shares Outstanding500M513M622M1.30B3.01B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms